ADAM10 and osteosarcoma: Furthermore, we indicate that knockdown of ADAM10 can inactivate E-cadherin/β-catenin signaling pathway, and ADAM10 knockdown inhibit tumorigenicity of osteosarcoma cells in the hypodermis of nude mice.